Company / Interest Expense per Share
Tarsus Pharmaceuticals, Inc. Interest Expense per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.23
FY2025
5-year range
$0.00 / $0.23
FY2021-FY2025
Trend
+1.6%
vs FY2024
Sector context
#19 of 43
Health Care
What the data says
At $0.23, Tarsus Pharmaceuticals, Inc.'s interest expense per share ranks #25 of 43 in the Health Care sector. Interest Expense per Share has increased for 3 consecutive years, from $0.00 in FY2022 to $0.23 in FY2025.
Based on SEC 10-K filings.
0.23 in FY2025.
Increased from $0.13 to $0.23 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#25 of 43 in Health CareTop 56% of 43This company $0.23 Sector average $18.61
▼
-98.7% below sector average
Key checks
Key Insights
- In FY2025, interest expense per share increased 1.6% year-over-year.
- Ranks #19 out of 43 companies in the Health Care sector.
- Lowest interest expense per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.23 | +1.6% |
| FY2024 | $0.23 | +83.1% |
| FY2023 | $0.13 | - |
| FY2022 | $0.00 | - |
| FY2021 | $0.00 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026